Catalyst Wire Dossier Catalyst Wire Dossier

Exjade

deferasirox · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

35 regulatory and trial events tracked for Exjade, covering 2007-04-20 to 2026-02-05. Get the full timeline:

Most recent: EMA Authorised: Exjade (deferasirox) — Novartis Europharm Limited

See pricing